Healthcare provider profile · identity verified

Joel Brown, MD

Family Practice · HINSDALE, IL · NPI 1831157452

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	335	98
Lisinopril	Lisinopril	213	61
Amlodipine Besylate	Amlodipine Besylate	187	47
Metformin Hcl Er	Metformin Hcl	164	49
Levothyroxine Sodium	Levothyroxine Sodium	163	43
Simvastatin	Simvastatin	141	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	140	36
Losartan Potassium	Losartan Potassium	102	27
Pioglitazone Hcl	Pioglitazone Hcl	94	24
Metoprolol Tartrate	Metoprolol Tartrate	93	26
Metoprolol Succinate	Metoprolol Succinate	92	26
Tamsulosin Hcl	Tamsulosin Hcl	89	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	17
Hydrochlorothiazide	Hydrochlorothiazide	84	27
Allopurinol	Allopurinol	71	24
Tramadol Hcl	Tramadol Hcl	67	12
Alprazolam	Alprazolam	63	19
Rosuvastatin Calcium	Rosuvastatin Calcium	62	17
Glimepiride	Glimepiride	60	18
Omeprazole	Omeprazole	51	14
Jardiance	Empagliflozin	50	16
Irbesartan	Irbesartan	49	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	17
Furosemide	Furosemide	41	16
Pravastatin Sodium	Pravastatin Sodium	41	13
Xarelto	Rivaroxaban	40	suppressed
Finasteride	Finasteride	38	12
Metformin Hcl	Metformin Hcl	36	13
Lorazepam	Lorazepam	35	suppressed
Gabapentin	Gabapentin	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Eliquis	Apixaban	32	11
Farxiga	Dapagliflozin Propanediol	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	28	13
Methylprednisolone	Methylprednisolone	27	16
Naproxen	Naproxen	27	13
Ozempic	Semaglutide	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Icosapent Ethyl	Icosapent Ethyl	24	suppressed
Meloxicam	Meloxicam	23	suppressed
Sildenafil Citrate	Sildenafil Citrate	23	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Atenolol	Atenolol	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Azithromycin	Azithromycin	18	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Indapamide	Indapamide	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Cefdinir	Cefdinir	14	12
Clonazepam	Clonazepam	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Mirtazapine	Mirtazapine	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Donepezil Hcl	Donepezil Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error